# Danville Regional Medical Center – FDA Inspection, Apr 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/danville-regional-medical-center/f160ffce-1ce4-40bc-a297-4010e2363786
Source feed: FDA_Inspections

> FDA inspection 1090102 of Danville Regional Medical Center, April 25, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 606 and 630. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1090102
- Company Name: Danville Regional Medical Center
- Inspection Date: 2019-04-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1246222 - 2024-07-30

## Related Officers

- [Company Rep](https://www.keypedia.com/people/randy-l-clarida/aae3cc15-a908-4489-9299-7542370ad3cd)

Company: https://www.keypedia.com/companies/danville-regional-medical-center/de4b0616-bb72-4419-a44e-b429b49d02ad

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
